Cargando…
Current Advances in Pharmacotherapy and Technology for Diabetic Retinopathy: A Systematic Review
Diabetic retinopathy (DR) is classically defined by its vascular lesions and damage in the neurons of the retina. The cellular and clinical elements of DR have many features of chronic inflammation. Understanding the individual cell-specific inflammatory changes in the retina may lead to novel thera...
Autores principales: | Lu, Lei, Jiang, Ying, Jaganathan, Ravindran, Hao, Yanli |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5822768/ https://www.ncbi.nlm.nih.gov/pubmed/29576875 http://dx.doi.org/10.1155/2018/1694187 |
Ejemplares similares
-
Corrigendum to “Current Advances in Pharmacotherapy and Technology for Diabetic Retinopathy: A Systematic Review”
por: Lu, Lei, et al.
Publicado: (2018) -
Novel Pharmacotherapies in Diabetic Retinopathy
por: Dedania, Vaidehi S., et al.
Publicado: (2015) -
Novel pharmacotherapies in diabetic retinopathy: Current status and what's in the horizon?
por: Das, Arup, et al.
Publicado: (2016) -
Pharmacotherapies for Diabetic Retinopathy: Present and Future
por: Schwartz, Stephen G., et al.
Publicado: (2007) -
Advances in pharmacotherapy of cataracts
por: Xu, Jingjie, et al.
Publicado: (2020)